Intercure Ltd.

INCR

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001857030

SEC filings (opens in a new tab)

No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Intercure Ltd. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of INCR: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Q4 2023	Change
Holders	20	18	−2
Shares	3.46M	3.80M	+339.2K (+9.8%)
Value	$5.43M	$4.93M	−$499.1K (−9.2%)

New holders (1)

Institutions that held Intercure Ltd. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to INCR in Q4 2023
Institution	Shares	Value	% of portfolio
Moore Capital Management, LP	97,273	$124.5K	0.00%

Sold out (3)

Institutions that held Intercure Ltd. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of INCR in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Connective Capital Management, LLC	49,264	$77.3K
Susquehanna International Group, LLP	14,658	$23.2K
Bank of America Corp	171	$268